Revenue and Income - Revenue for the fiscal 2026 third quarter increased by 18.0% to $41.8 million, up from $35.4 million in the same quarter last year[7] - Net income rose to $1.2 million, or $0.09 per diluted share, compared to $6,000, or $0.00 per diluted share, in the same quarter last year[12] - Net income for the nine months ended December 31, 2025, was $1,959,393, a significant improvement from a net loss of $695,834 in the same period of 2024[24] Gross Margin and Operating Income - Gross margin improved by 170 basis points to 16.9%, compared to 15.2% in the prior year quarter[7] - Operating income nearly tripled to $1.9 million, from $708,000 in the same quarter last year[7] Future Revenue Expectations - Revenue for the fiscal 2026 fourth quarter is expected to increase by 23% to 26% over $29.3 million in the prior-year quarter[7] Expenses and Cash Flow - Operating expenses totaled $5.1 million in the fiscal 2026 third quarter, compared to $4.7 million in the same quarter last year[10] - The company reported a net cash used in operating activities of $3,491,495 for the nine months ended December 31, 2025, compared to $581,275 in the same period of 2024[24] Assets and Liabilities - Cash and restricted cash totaled $13.2 million, and net working capital was $36.4 million as of December 31, 2025[17] - Total current assets increased to $56,769,635 as of December 31, 2025, compared to $54,420,209 on March 31, 2025, reflecting a growth of 4.3%[23] - Accounts receivable increased to $7,831,553 as of December 31, 2025, compared to $3,076,074 on March 31, 2025, indicating a rise of 154%[23] - Total liabilities rose to $20,563,722 as of December 31, 2025, up from $20,106,417 on March 31, 2025, marking an increase of 2.3%[23] - Total equity increased to $63,651,208 as of December 31, 2025, from $62,869,109 on March 31, 2025, reflecting a growth of 1.2%[23] Dividend Information - A regular quarterly dividend of $0.05 per share was approved, payable on February 20, 2026[17] - The company made dividend payments totaling $1,904,991 during the nine months ended December 31, 2025, compared to $1,844,226 in the same period of 2024[24] Depreciation and Interest - The company incurred depreciation expenses of $2,274,388 for the nine months ended December 31, 2025, compared to $1,968,992 in the same period of 2024[24] - Cash paid for interest was $1,242,520 for the nine months ended December 31, 2025, slightly lower than $1,348,291 in the same period of 2024[24] Production Capacity - The acquisition of a bank-owned manufacturing building is expected to increase production capacity by at least 40%[5] Comprehensive Income - Comprehensive income attributable to common stockholders advanced to $1.2 million in the fiscal 2026 third quarter, from a comprehensive loss of $147,000 in the same quarter last year[12]

Revenue Expectations - Record fourth quarter 2025 revenue is expected to be between $103.0 million and $106.0 million, representing an approximate 13% increase compared to $91.4 million in Q4 2024[6] - Full year 2025 revenue is expected to range between $374.0 million and $378.0 million, an increase of approximately 15% compared to full year 2024, achieved with approximately 14% fewer aircraft[6] Net Loss Projections - Net loss for Q4 2025 is expected to range between $(13.0) million and $(10.0) million, an improvement compared to a net loss of $(16.5) million in Q4 2024[6] - Full year 2025 net loss is expected to range between $(73.0) million and $(70.0) million, an improvement of approximately 30% compared to a $(101.5) million loss in 2024[6] Adjusted EBITDA - Fourth quarter 2025 Adjusted EBITDA is expected to range between $5.5 million and $8.0 million, marking the Company's first quarter of positive Adjusted EBITDA[6] - Full year 2025 Adjusted EBITDA is expected to range between $(8.5) million and $(5.0) million, representing an improvement of approximately $50 million from full year 2024[6] Financial Management - The Company reduced total long-term notes payable by more than $80 million compared to 2024 while maintaining cash position year-over-year[4] Strategic Investments - The investment in high-performing Challenger aircraft and improved fleet optimization contributed to historic top-line growth and significantly improved profitability[5] Customer Experience Enhancements - The Company has a Starlink dealership agreement, with installation in aircraft expected to begin in Q1 2026, enhancing customer experience[5] Upcoming Events - The Company plans to host a conference call on March 5, 2026, to discuss its financial results for Q4 and full year 2025[8]

flyExclusive Reports Record Preliminary Unaudited Results for the Fourth Quarter and Full Year 2025, Capping a Transformational Year with Expected Positive Adjusted EBITDA in Fourth Quarter 2025. Reduced Long-Term Notes Payable more than $80 Million Compared to 2024 while Maintaining Cash Position Year-over-Year. Kinston, N.C. – February 9, 2026 - flyExclusive, Inc. (NYSE American: FLYX), one of the nation's largest private jet operators, today announced preliminary unaudited financial results for its fourt ...

Financial Performance - Net sales for the fiscal 2026 third quarter were $167.7 million, down from $186.2 million in the prior year, reflecting a decrease of approximately $17 million due to reduced ordering from a large customer[3]. - Gross profit for the fiscal 2026 third quarter was $32.9 million, compared to $44.9 million a year earlier, resulting in a gross margin of 19.6%, down from 24.1%[4]. - Operating income for the fiscal 2026 third quarter was $8.3 million, a decrease from $17.6 million in the prior year, while interest expense decreased by $3.5 million to $10.9 million[6]. - Net income for the fiscal 2026 third quarter was $1.8 million, or $0.09 per diluted share, compared to $2.3 million, or $0.11 per diluted share, in the prior year[7]. - For the nine-month period, net sales increased by $13.3 million, or 2.4%, to $577.5 million, despite a $40 million decrease from the previously noted customer[12]. - Gross profit for the nine-month period was $109.5 million, with a gross margin of 19.0%, down from 20.4% a year earlier[14]. - GAAP net income for the three months ended December 31, 2025, was $1.78 million, or $0.09 per diluted share, compared to $2.29 million, or $0.11 per diluted share for the same period in 2024, reflecting a decrease of 22.4%[32]. - For the nine months ended December 31, 2025, GAAP net income was $2.67 million, or $0.13 per diluted share, a recovery from a loss of $18.75 million, or $(0.95) per diluted share in 2024[33]. - GAAP gross profit for the three months ended December 31, 2025, was $32.88 million, with a gross margin of 19.6%, down from $44.88 million and a gross margin of 24.1% in 2024[35]. - The company reported a GAAP gross profit of $109.52 million for the nine months ended December 31, 2025, with a gross margin of 19.0%, down from $115.33 million and a margin of 20.4% in 2024[36]. Cash Flow and Debt Management - The company generated cash of approximately $23.7 million for the nine-month period and reduced net bank debt by $10.9 million to $70.5 million[10]. - Cash items impacting net income for the nine months ended December 31, 2025, amounted to $1.89 million, compared to $3.33 million in 2024, showing a decrease in cash-related impacts[33]. - Total current liabilities increased to $390.79 million as of December 31, 2025, from $351.03 million on March 31, 2025, marking an increase of 11.3%[28]. - The company’s total liabilities rose to $732.76 million as of December 31, 2025, compared to $699.94 million on March 31, 2025, reflecting a growth of 4.7%[28]. - The company’s retained earnings increased to $22.70 million as of December 31, 2025, up from $20.03 million on March 31, 2025, indicating a growth of 13.3%[28]. Future Outlook - The company is revising its fiscal 2026 sales guidance to between $750 million and $760 million, with operating income expected to be between $72 million and $79 million[19]. - The company anticipates further opportunities to enhance shareholder value through improved profitability and a return to normal ordering activity[18]. - Significant new business commitments are expected due to changes in the competitive landscape, including the bankruptcy of a competitor and increased demand for replacement parts[5]. Non-Cash and Other Financial Items - Non-cash items impacting net income for the three months ended December 31, 2025, totaled $313,000, compared to $4.96 million in 2024, indicating a significant reduction in non-cash impacts[32]. - Total non-cash items impacting EBITDA for Q3 2025 amounted to $418,000, significantly lower than $6,615,000 in Q3 2024[37]. - The company incurred new product line start-up costs of $397,000 in Q3 2025, compared to $4,438,000 in the same quarter of the previous year[37]. - Depreciation and amortization for Q3 2025 was $2,359,000, slightly down from $2,532,000 in Q3 2024[37]. - Income tax expense for Q3 2025 was $(434,000), a significant decrease from $1,115,000 in Q3 2024[37]. EBITDA Performance - EBITDA for Q3 2025 was $14,603,000, down from $20,373,000 in Q3 2024, representing a decline of approximately 28%[37]. - Total EBITDA for the nine months ended December 31, 2025 was $51,815,000, an increase from $33,967,000 in the same period of 2024[37].

Exhibit 99.1 Powerfleet Reports Robust Q3 Recurring Revenue Growth With11% Year-Over-Year Increase in Services Revenue Total revenue increased 7% year-over-year to a record $113.5 million from $106.4 million in Q3 FY25 Services revenue increased 11% to $91.1 million from $81.7 million in Q3FY25 Operating profit of $6.3 million, compared to an operating loss of $1.2 million in Q3 FY25 Net Loss improved to $3.4 million compared to $14.3 million in Q3 FY25 Adjusted EBITDA increased 26% to $25.7 million from $2 ...

Exhibit 99.1 Powerfleet Reports Robust Q3 Recurring Revenue Growth With11% Year-Over-Year Increase in Services Revenue Total revenue increased 7% year-over-year to a record $113.5 million from $106.4 million in Q3 FY25 Services revenue increased 11% to $91.1 million from $81.7 million in Q3FY25 Operating profit of $6.3 million, compared to an operating loss of $1.2 million in Q3 FY25 Net Loss improved to $3.4 million compared to $14.3 million in Q3 FY25 Adjusted EBITDA increased 26% to $25.7 million from $2 ...

"As we have entered 2026, we continue to progress our innovative clinical pipeline with particular focus on our lead candidate, oral blarcamesine in early Alzheimer's disease. Based on our commitment to improving the lives of patients with neurological disorders, we remain excited about the therapeutic potential of oral blarcamesine. We look forward to working with the regulatory agencies in Europe and the U.S. to advance oral blarcamesine as a potential new treatment option for patients." said Christopher ...

Exhibit 99.1 Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update WEST LAFAYETTE, IN, February 9, 2026 – Inotiv, Inc. (Nasdaq: NOTV) (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months ("Q1 FY 2026") ended December 31, 2025. Revenue by Segment (in millions of USD) | | Three ...

Financial Performance - Kyndryl reported revenues of $3.9 billion for Q3 FY2026, a 3% increase year-over-year, with net income of $57 million, or $0.25 per diluted share[4]. - Adjusted pretax income was $168 million, reflecting an $8 million increase from the prior year, while adjusted net income was $122 million, or $0.52 per diluted share[5]. - Total revenue for the three months ended December 31, 2025, was $3,859 million, representing a 3% year-over-year growth[22]. - Net income for Q4 2025 was $57 million, a decrease from $215 million in Q4 2024, resulting in a net income margin of 1.5%[37]. - Adjusted EBITDA for Q4 2025 was $696 million, compared to $704 million in Q4 2024, with an adjusted EBITDA margin of 18.0%[37]. - Adjusted net income for the nine months ended December 31, 2025 was $301 million, compared to $159 million for the same period in 2024[37]. - Adjusted earnings per share (EPS) for Q4 2025 was $0.52, slightly up from $0.51 in Q4 2024[37]. Revenue Growth - Kyndryl Consult achieved a revenue growth of 24% year-over-year, with total revenues of $3.6 billion and signings of $4.1 billion over the last twelve months[8]. - The company generated $500 million in revenue from hyperscaler alliances, marking a 58% year-over-year increase, and is on track to exceed its fiscal 2026 target of $1.8 billion[8]. - Signings for the trailing twelve months reached $15.4 billion, with eleven customer contracts signed in Q3 exceeding $50 million each[7]. - Total signings for Q4 2025 were $3.9 billion, down from $4.1 billion in Q4 2024, with currency movements contributing five points to signings growth[40]. Cash Flow and Expenditures - Free cash flow for the quarter was $217 million, compared to $260 million in the prior-year period[5]. - Cash flows from operating activities for Q4 2025 were $427 million, compared to $260 million in Q4 2024[39]. - The company reported a net change in cash, cash equivalents, and restricted cash of $(437) million for the nine months ended December 31, 2025[24]. - The company experienced a decrease in net capital expenditures, which were $210 million in Q4 2025 compared to $93 million in Q4 2024[39]. - Capital expenditures for the nine months ended December 31, 2025, were $492 million, up from $365 million in 2024[24]. Share Repurchase and Debt - The company repurchased 3.7 million shares for $100 million in Q3, totaling 11 million shares repurchased for $349 million since the program's authorization[8]. - The company repurchased $250 million in common stock during the nine months ended December 31, 2025, compared to $30 million in the previous year[24]. - The total debt (short-term and long-term) was $3,100 million as of December 31, 2025[22]. Future Outlook - Kyndryl's fiscal year 2026 outlook includes adjusted pretax income of $575 to $600 million and free cash flow of $325 to $375 million[12]. - The projected pretax margin associated with recent signings is in the high-single-digit range, indicating strong profitability potential[8].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended December 31, 2025 or ☐ Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File No. 0-22818 THE HAIN CELESTIAL GROUP, INC. (Exact name of registrant as specified in its charter) (State or other juri ...